|会社名||Cooper Companies Inc. (The) （COO ク―パ―）|
|業種||医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care）|
|概要||事業概要 クーパー・カンパニーズ（The Cooper Companies Inc.）はグローバルな医療機器会社である。同社はCooperVision IncとCooperSurgical Incの2つ事業を通じて運営する。CooperVisionは視力矯正市場向けソフトコンタクトレンズを提供し、1日・2週間・1か月使い捨てコンタクトレンズを開発・製造・販売し、米州、ヨーロッパ･中東･アフリカ（EMEA）、アジア太平洋地域にサービスを提供する。CooperVisionは球面、非球面、トーリック、多焦点、トーリック多焦点レンズ製品を様々なモダリティで提供する。CooperVisionは主に英国、プエルトリコ、ハンガリー、コスタリカ、ニューヨークで製品を生産する。CooperSurgicalは女性健康、妊娠と診断に焦点を当てた製品・サービスポートフォリオを通じて、家庭健康を向上させる製品およびサービスを提供する。 ク―パ―は米国の医療器具メ―カ―。「バイオフィニティ」、「アバイラ」、「プロクリア」のブランド名で、シリコンハイドロゲルレンズ、乱視用レンズ、多焦点レンズなどのソフトコンタクトレンズ製品の開発、製造、販売を行う。また女性の健康管理・治療に携わる病院、産婦人科医院、不妊治療クリニックなどに医療器具を提供する。 CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.|
|代表者氏名||A. Thomas Bender|
|代表者役職名||Independent Chairman of the Board|
|決算概要||決算概要 BRIEF: For the three months ended 31 January 2019 Cooper Companies Inc revenues increased 6% to $628.1M. Net income before extraordinary items increased 6% to $84.5M. Revenues reflect CooperVision Inc. segment increase of 6% to $470.1M Cooper Surgical segment increase of 9% to $158M United States segment increase of 7% to $278.9M Rest of the World segment increase of 12% to $139.5M Europe segment increase of 3% to $209.7M.|
The Cooper Companies, Inc. – Consensus Indicates Potential 9.2% Upside 2022/12/06 13:33:42 DirectorsTalk
The Cooper Companies, Inc. with ticker code (COO) have now 11 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 560 and 280 and has a mean target at 352.09. Now with the previous closing price of 322.32 this is indicating there is a potential upside of 9.2%. There is a 50 day moving average of 282.04 and the 200 day moving average is 330.38. The market capitalisation for the company is $15,868m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,333m based on the market concensus. 0 This article The Cooper Companies, Inc. – Consensus Indicates Potential 9.2% Upside first appeared on DirectorsTalk Interviews .
This little-known contact lenses stock can surge 20% from here, Baird says 2022/11/30 12:59:52 CNBC
There''s big upside in shares of Cooper Companies, a company known for manufacturing contact lenses, according to Baird.
Baird Upgrades Cooper Companies to Outperform 2022/11/30 07:06:02 Investing.com
Cooper Companies PT Raised to $330 at JPMorgan 2022/11/28 14:29:03 Investing.com
Quant Ratings Updated on 103 Stocks 2022/11/15 21:30:08 InvestorPlace
Last week the markets saw their best single-session gain in more than two years as investors celebrated the favorable Consumer Price Index ( CPI ) reading. And then today’s Producer Price Index (PPI) had Wall Street cheering again. PPI increased 0.2% in October, which was less than economists’ expectations for a 0.4% increase. PPI rose 8% year-over-year, which was also below economists’ forecasts for an 8.4% rise. Core PPI, which excludes food, energy and trade services, climbed 0.2% in October and 5.4% year-over-year. Out of the S&P 500, Dow and NASDAQ, the tech-heavy NASDAQ staged the biggest rally – as of this writing, it’s up more than 1% today and up nearly 8% since November 4. On the flip side, the 10-year Treasury fell below 3.8% this morning and is well off its November high of 4.22%. As investors dip their toes back into the tech sector, some tech stocks are beginning to find their groove again in Portfolio Grader , too. Case in point: United Microelectronics Corp. ( UMC ). For the last several months, this leading global semiconductor foundry has come under pressure along with the semiconductor sector.
The Cooper Companies, Inc. (COO) CEO Al White on Q1 2022 Results - Earnings Call Transcript 2022/03/04 04:06:02 Seeking Alpha
The Cooper Companies (COO) Q1 2022 Earnings Call Transcript 2022/03/04 03:30:36 The Motley Fool
COO earnings call for the period ending December 31, 2021.
The Cooper Companies Non-GAAP EPS of $3.24 beats by $0.14, revenue of $787.2M beats by $47.9M 2022/03/03 21:27:17 Seeking Alpha
The Cooper Companies press release (COO): Q1 Non-GAAP EPS of $3.24 beats by $0.14.Revenue of $787.2M (+15.7% Y/Y) beats by $47.9M.Fiscal 2022 total revenue $3,261 - $3,329…
The Cooper Companies – Consensus Indicates Potential 14.7% Upside 2022/03/01 10:19:33 DirectorsTalk
The Cooper Companies with ticker code (COO) now have 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 560 and 405 and has a mean target at 471.33. With the stocks previous close at 410.89 this is indicating there is a potential upside of 14.7%. The 50 day MA is 401.9 and the 200 day moving average is 408.59. The company has a market cap of $20,163m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets=COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $23,129m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Endoscopy Equipment Market : Analysis of Potential Market Opportunity Worth USD 39.3 Billion by 2026 2022/02/24 19:18:00 SBWire
Endoscopy Equipment Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow. Northbrook, IL -- ( SBWIRE ) -- 02/24/2022 -- This report aims to provide detailed insights into the global endoscopy equipment market . It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market. Expected Revenue Growth: The global endoscopy equipment market is projected to reach USD 39.3 billion by 2026 from USD 27.3 billion in 2021, at a CAGR of 7.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689 Key Factors Driving Market Growth: The key factors driving the growth of endoscopy equipment market include favorable government initiatives, rising number of hospitals and growing hospital investments in endoscopy facilities, technological advancements, and rising prevalence of diseases that require endoscopy.
What Wall Street expects from Cooper Cos's earnings 2021/06/01 13:01:19 Business Insider Markets
Cooper Cos will be reporting Q2 earnings on June 3. Wall Street analysts expect Cooper Cos will be reporting earnings per share of $3.09. Go here to track Cooper Cos stock price in real-time ahead of earnings. On June 3,…